Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Senegal loses $7m malaria grant:

This article was originally published in Clinica

Executive Summary

The Global Fund to fight AIDS, Malaria and Tuberculosis has withdrawn Senegal's $7.1m five-year grant to tackle malaria. Citing "systemic issues that resulted in poor performance" against initial two-year targets, the decision constitutes the Global Fund's first formal discontinuation and is encouraging the country to re-apply. Senegal was part of the first ever round of phase 1 evaluations conducted by the Global Fund. Another 21, with a value of $119m, were approved for a second three-year phase; three grants remain under review. The Global Fund currently has $3.1bn in phase-1 grants in 127 countries.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT054499

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel